| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/24/2005 | WO2004102199A3 Method for selecting and producing vaccine components and vaccines based thereon |
| 02/24/2005 | WO2004101762A3 Detection and treatment of cancers of the colon |
| 02/24/2005 | WO2004098535A9 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/24/2005 | WO2004092219A3 Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis |
| 02/24/2005 | WO2004073656A3 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 02/24/2005 | WO2004056865A3 Method of modulation of interaction between receptor and ligand |
| 02/24/2005 | WO2004052293A3 Recombinant vaccine against flavivirus infection |
| 02/24/2005 | WO2004042352A3 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 02/24/2005 | WO2004005530A3 Compositions and methods for treatment and detection of multiple cancers |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003059273A3 Antibody-avidin fusion proteins as cytotoxic drugs |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | WO2003037400A3 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043521 Recovering viral particle and using single chain Fv antibodies specific for subsets of blood leukocytes to isolate and detect blood and fetal bone marrow cells |
| 02/24/2005 | US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/24/2005 | US20050043519 Generating immunoglobulin specific to novel antigen receptor (NAR) for use in innunodiagnostic and immunotherapy |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043517 Method for generating antibodies |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043515 Tobacco-specific nitrosamine detection assays and reagents |
| 02/24/2005 | US20050043514 Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate |
| 02/24/2005 | US20050043512 Human glioma antigen originating in testis |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050042775 Botulinum antitoxin compositions and methods |
| 02/24/2005 | US20050042747 Immunoglobulin mixture which prevents and/or reduces viral associated with cells; immunotherapeutic and g-protein binding |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042721 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | US20050042718 Using transgenic cells to generate monoclonal antibodies for use in immunodiagnostics and tissue directed therapy |
| 02/24/2005 | US20050042702 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 02/24/2005 | US20050042701 Bioconjugates; metabolites; kits; bioavailbility; pharmacokinetics |
| 02/24/2005 | US20050042699 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 02/24/2005 | US20050042691 Methods for identifying active compounds |
| 02/24/2005 | US20050042685 Using bispecific antibodies comprising magnetic particle to separate and identify tumorigenic testicular tissue in solution |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042664 Humanization of antibodies |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042652 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 02/24/2005 | US20050042636 Using semaphorin-5 gene expression as diagnostic indicator of cell proliferative disorders; tissue engineering; tissue targeted therapy |
| 02/24/2005 | US20050042632 (Monoclonal) antibodies having binding affinity for a nucleic acid molecule having a 2'-deoxy-2'-C-allyl Uridine nucleoside and/or nucleotide; short interference RNA; drug screening; bioavailability |
| 02/24/2005 | US20050042631 Cloning and characterization of two novel m-RNA transcription factors |
| 02/24/2005 | US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases |
| 02/24/2005 | US20050042230 Administering respiratory syncytial virus G protein immunogen or fragment |
| 02/24/2005 | US20050042226 Treatment of chronic human viral hepatitis |
| 02/24/2005 | US20050042223 Hybridoma cell line producing anti-CTLA4 (cytotoxic T-lymphocyte antigen 4) antibodies; cancer treatment; biodrugs |
| 02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |
| 02/24/2005 | US20050042221 Purified antibody directed against modified beta -amyloid peptide comprising malondialdehyde adduct; medical research involving amyloid precursor protein (APP)-metabolism; enzyme-linked immunosorbent assays |
| 02/24/2005 | US20050042220 Antigen binding fragments; rheumatoid arthritis, osteoarthritis, multiple sclerosis, myasthenia gravis, Crohn*s disease, inflammatory bowel disease, lupus, diabetes, psoriasis, asthma, chronic obstructive pulmonary disease, cardiovascular inflammation, pancreatitis, hepatitis, and nephritis |
| 02/24/2005 | US20050042219 Engineered Fab' fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs |
| 02/24/2005 | US20050042218 Vaccines for treating and/or preventing cancer, infections, autoimmune diseases, and/or allergies |
| 02/24/2005 | US20050042216 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 02/24/2005 | US20050042214 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 02/24/2005 | US20050042209 Enhancing the induction apoptosis in a MUC1 expressing cancer cell by a pro-apoptotic drugs; antiproliferative agents |
| 02/24/2005 | US20050042205 Purification and cloning of receptors for luteinizing hormone, choriogonadotropin, follicle stimulating hormone, and/or thyroid stimulating hormone; fertility, breast or prostate cancer, benign prostatic hypertrophy, vasomotor instability, osteoporosis, and polycystic ovarian disease; genetic engineering |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | DE10335131A1 Porous carbon moldings, e.g. for catalyst support; insulant, tube membrane, ex or in vivo cell culture substrate or scaffold or implant, are made by molding carbonizable polymer and removing filler or partial oxidation to form pores |
| 02/24/2005 | CA2762015A1 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | CA2536235A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | CA2535901A1 Ups as modifiers of the beta catenin pathway and methods of use |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2535618A1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 02/24/2005 | CA2535515A1 Cd20-binding polypeptide compositions |
| 02/24/2005 | CA2535508A1 A new class of .alpha.2.delta. calcium channel subunits |
| 02/24/2005 | CA2535489A1 Antibodies against factor viii with modified glycosylation in the variable region |
| 02/24/2005 | CA2535261A1 Prion-specific peptide reagents |
| 02/24/2005 | CA2535156A1 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 02/24/2005 | CA2535071A1 Modified human igf-1r antibodies |
| 02/24/2005 | CA2535007A1 Nogo receptor antagonists |
| 02/24/2005 | CA2534875A1 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal |
| 02/24/2005 | CA2534563A1 Antibodies to c-met |
| 02/24/2005 | CA2534474A1 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | CA2533921A1 Binding constructs and methods for use thereof |
| 02/24/2005 | CA2533830A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | CA2533382A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 02/24/2005 | CA2532553A1 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 02/24/2005 | CA2532027A1 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | CA2531595A1 Reducing protein a leaching during protein a affinity chromatography |
| 02/24/2005 | CA2526120A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | CA2525647A1 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/24/2005 | CA2524737A1 Antibodies that immunospecifically bind to trail receptors |
| 02/24/2005 | CA2524305A1 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/23/2005 | EP1508614A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/23/2005 | EP1508576A1 Efficient production of IgA in recombinant mammalian cells |
| 02/23/2005 | EP1508574A2 Long wavelength engineered fluorescent proteins |
| 02/23/2005 | EP1508339A1 Tuberculosis vaccine |
| 02/23/2005 | EP1508337A2 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 02/23/2005 | EP1508043A2 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 02/23/2005 | EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof |
| 02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |
| 02/23/2005 | EP1507861A2 Vaccines |
| 02/23/2005 | EP1507859A2 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 02/23/2005 | EP1507857A1 Novel pectinases and uses thereof |
| 02/23/2005 | EP1507856A1 Regulation of human serine/threonine kinase |
| 02/23/2005 | EP1507801A1 Antibodies and their use for the modulation of taste sensation |
| 02/23/2005 | EP1507790A2 Human genes and gene expression products isolated from human prostate |